Blog / Archives
Biotech ETF Trending Shows Shift To Speculative Stocks: XBI
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well. Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc Rapid Fire...
ASCO Rally Fades But Spec Stocks Rock: FCSC,RXDX
ASCO Week in Review- Rayno Biopharmaceutical Stocks The market action over the past week focused on speculative stocks rather than the overall biopharmaceutical sector. Major ETFs over five days...
ASCO 2015 Biotech Movers Day Two: FCSC, JUNO, RXDX
Update-1 BLUE Drops 1.96% and 1.77% After Hours 6/3 In the bubbly CAR-T world bluebird bio (BLUE) and Celgene announced a deal for for development of product candidates for B-cell maturation...
Rayno Biopharma Stocks at ASCO: ARRY, CLVS, RXDX
Biotech Indices Can't Break Through Triple Top IBB at $365, XBI at $239 Red and green day Biotech stocks were mixed today with the major indices holding the flat line. However with all of the...
Biotech (IBB) 2015 Triple Top Is Here ! NASDAQ Hits New High…Update
Update-1 Mixed Market but CAR-T stocks soar Biotechs could not break through the top today and were down about 0.5%. The XBI and XLV did a little better almost flat. Red and green were just about...
Regulatory News for Rare Disease Products-Hot Stocks: BLUE,ICPT,SRPT …Updates
Update-2 uniQure up on deal with BMY (CURE) Cardiovascular Deal with Bristol Myers (BMY) The closing of the uniQure deal with Bristol Myers triggered a $50M payment. Three collaboration targets in...
Rayno Life Science Stocks Move Higher: CLVS, RHHBY-ASCO Preview
Rayno Biopharmaceutical Stocks- ASCO Plays or Not Large Caps Rule Clovis Oncology (CLVS) up 16.7%, 79% YTD to $100 level! Several data CLVS Presentations for ASCO including two oral and six posters...
Hot Biotech Sector: Mid-Caps Have Both M&A and Pipeline Premiums
Valuations Step-Up With More Deals Prior to the acquisition of Pharmacyclics (PCYC) by Abbvie (ABBV) for $20B, the top price paid for an emerging biotech company was in the $10B range. Two...
Biotechs Tag Along With Broad Market Rally: FBT Up 3%
Jobs Report Drive Stocks Higher-DOW Up 1.5% Stocks moved higher on the "goldilocks" job report which showed a gain of 223k added in April. The jobs number was too high to raise concerns about an...
M&A Sparks Biotechs: Alexion Buys Syngeva for $8.4B…Update-1
Orphan Drugs-The Latest Hot Spot in Biotech Large Cap Biotechs Were Red-Specualtive Stocks Were Green XBI 214.9 up 2.36% GEVA $203.4 up 112% NASDAQ 4919 down 0.4% Rare Disease Companies Merge:...